Aptevo Therapeutics Balance Sheet (2015-2025) | APVO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Assets
Current Assets
Cash & Equivalents (Quarter)	42.53M	58.78M	61.65M	53.38M	45.04M	36.25M	29.43M	22.58M	22.64M	25.33M	21.01M	1.60M	3.73M	10.25M	8.07M	7.75M	7.53M	2.14M	8.10M	3.23M
Short-term Investments (Quarter)	2.56M	1.26M	1.26M	1.26M
Cash & Current Investments (Quarter)	45.09M	60.04M	62.91M	54.64M	45.04M	36.25M	29.43M	22.58M	22.64M	25.33M	21.01M	1.60M	3.73M	10.25M	8.07M	7.75M	7.53M	2.14M	8.10M	3.23M
Receivables - Net (Quarter)
Receivables - Other (Quarter)	2.37M	2.42M	3.11M	3.10M	3.66M	3.11M
Receivables (Quarter)
Raw Materials (Quarter)
Work In Process (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)
Prepaid Assets (Quarter)	2.23M	0.08M	0.07M	0.01M	0.78M	1.43M	0.77M	0.66M	0.74M	1.57M	0.76M	1.37M	0.69M	1.13M	0.71M	1.64M	1.02M	1.35M	0.08M	1.51M
Current Assets (Quarter)	47.26M	62.85M	65.77M	58.87M	52.57M	41.67M	31.40M	24.62M	27.45M	28.48M	22.68M	21.13M	19.07M	12.07M	9.58M	10.01M	10.66M	3.61M	11.08M	22.65M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	2.81M	2.71M	2.80M	2.52M	2.38M	2.14M	1.89M	1.67M	1.46M	1.28M	1.13M	1.01M	0.90M	0.79M	0.70M	0.61M	0.54M	0.48M	0.43M	0.38M
Goodwill (Quarter)
Intangibles (Quarter)
Goodwill & Intangibles (Quarter)
Other Non-Current Assets (Quarter)	2.56M	0.75M	0.75M	0.75M	1.26M	1.26M	0.55M	0.43M
Non-Current Assets (Quarter)	6.28M	5.90M	5.71M	5.13M	4.03M	3.51M	7.40M	7.08M	6.76M	6.48M	6.23M	6.00M	5.78M	5.55M	5.34M	5.13M	4.93M	4.74M	4.54M	4.35M
Assets (Quarter)	53.55M	68.75M	71.47M	64.00M	56.60M	45.18M	38.80M	31.70M	34.22M	34.97M	28.91M	27.13M	24.84M	17.63M	14.92M	15.15M	15.59M	8.34M	15.62M	27.00M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	5.58M	5.35M	5.20M	3.69M	3.46M	3.91M	3.27M	3.24M	3.50M	4.13M	4.87M	4.00M	3.98M	3.72M	3.74M	3.53M	1.24M	3.79M	2.90M	2.22M
Payables (Quarter)	5.58M	5.35M	5.20M	3.69M	3.46M	3.91M	3.27M	3.24M	3.50M	4.13M	4.87M	4.00M	3.98M	3.72M	3.74M	3.53M	1.24M	3.79M	2.90M	2.22M
Accumulated Expenses (Quarter)	2.76M	1.10M	1.20M	1.56M	2.08M	1.04M	1.70M	1.37M	2.10M	0.63M	1.29M	1.52M	2.10M	1.61M	0.89M	0.92M	1.86M	0.47M	1.04M	1.90M
Other Accumulated Expenses (Quarter)	1.20M	0.98M	0.99M	2.59M	2.09M	1.59M	0.03M	1.17M	1.10M	1.04M	0.75M	1.31M	1.14M	0.97M	0.79M	1.43M	0.36M	1.13M	0.95M	1.49M
Short term Debt (Quarter)	5.00M	10.17M	10.67M	11.17M	11.67M	2.00M	2.00M	2.00M	2.00M
Current Leases (Quarter)																	0.80M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	14.54M	29.34M	30.86M	32.38M	34.76M	23.86M	7.00M	7.79M	8.71M	5.80M	6.91M	6.84M	7.22M	6.30M	5.42M	5.88M	6.21M	5.39M	4.89M	5.61M
Non-Current Liabilities
Non-Current Debt (Quarter)	20.05M	4.61M	4.32M	4.01M	3.71M	2.80M	2.36M	1.91M	1.46M
Non-Current Deffered Revenue (Quarter)
Liabilities from Discontinued Operations (Quarter)
Non-Current Deferred Tax Liability (Quarter)
Operating Leases (Quarter)	2.36M	2.12M	1.90M	1.60M	1.34M	1.10M	6.40M	6.20M	6.10M	5.90M	5.70M	5.60M	5.40M	5.20M	5.00M	4.80M	4.60M	4.42M	4.21M	4.00M
Other Non-Current Liabilities (Quarter)														0.01M	0.01M	0.01M
Total Non-Current Liabilities (Quarter)	36.95M				55.38M				16.24M				12.62M	11.51M	10.44M	10.71M	10.84M
Total Liabilities (Quarter)	36.95M	58.25M	57.59M	56.71M	55.38M	51.07M	15.75M	15.93M	16.24M	11.71M	12.66M	12.41M	12.62M	11.53M	10.46M	10.73M	10.84M	9.81M	9.10M	9.60M
Shareholder's Equity
Total Debt (Quarter)	25.05M	14.78M	14.99M	15.18M	15.37M	4.80M	4.36M	3.91M	3.46M
Common Equity (Quarter)	16.59M	10.50M	13.88M	7.29M	1.22M	-5.88M	23.05M	15.76M	17.97M	23.26M	16.25M	14.72M	12.22M	6.10M	4.46M	4.42M	4.75M	-1.47M	6.52M	17.39M
Shareholder's Equity (Quarter)	16.59M	10.50M	13.88M	7.29M	1.22M	-5.88M	23.05M	15.76M	17.97M	23.26M	16.25M	14.72M	12.22M	6.10M	4.46M	4.42M	4.75M	-1.47M	6.52M	17.39M
Liabilities and Shareholders Equity (Quarter)	53.55M	68.75M	71.47M	64.00M	56.60M	45.18M	38.80M	31.70M	34.22M	34.97M	28.91M	27.13M	24.84M	17.63M	14.92M	15.15M	15.59M	8.34M	15.62M	27.00M
Retained Earnings (Quarter)	-185.61M	-192.86M	-200.79M	-207.79M	-214.06M	-221.76M	-193.75M	-201.39M	-206.04M	-203.26M	-211.21M	-217.54M	-223.45M	-230.28M	-236.16M	-241.26M	-247.58M	-253.99M	-260.19M	-269.22M
Treasury Shares (Quarter)	0.01M	0.06M	0.06M	0.06M	0.06M				0.22M				175.00				1.00

Research Tools

Aptevo Therapeutics Balance Sheet (2015-2025) | APVO

Create an account

Sign In

Reset Password